| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 109.28B | 118.61B | 111.05B | 104.28B | 97.91B | 87.62B |
| Gross Profit | 39.04B | 43.65B | 39.49B | 34.59B | 33.74B | 28.03B |
| EBITDA | 11.19B | 11.94B | 11.82B | 8.45B | 9.11B | 9.43B |
| Net Income | 7.05B | 7.37B | 7.25B | 4.64B | 5.72B | 6.16B |
Balance Sheet | ||||||
| Total Assets | 181.56B | 178.16B | 172.91B | 167.59B | 165.52B | 157.08B |
| Cash, Cash Equivalents and Short-Term Investments | 62.56B | 54.43B | 59.47B | 50.61B | 63.36B | 63.92B |
| Total Debt | 19.96B | 10.98B | 12.24B | 11.56B | 11.31B | 11.90B |
| Total Liabilities | 68.22B | 55.26B | 57.41B | 53.12B | 58.39B | 53.70B |
| Stockholders Equity | 113.33B | 122.90B | 115.50B | 114.47B | 106.97B | 103.29B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -304.00M | 14.74B | -9.60B | 2.76B | 7.36B |
| Operating Cash Flow | 0.00 | 3.53B | 17.02B | -8.05B | 4.47B | 9.28B |
| Investing Cash Flow | 0.00 | -2.91B | -4.78B | 483.00M | -526.00M | -1.38B |
| Financing Cash Flow | 0.00 | -6.07B | -4.31B | -4.87B | -4.08B | -2.94B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥64.91B | 11.47 | ― | 3.95% | 2.75% | 25.75% | |
79 Outperform | ¥136.97B | 16.51 | ― | 3.24% | 8.95% | 18.54% | |
76 Outperform | ¥75.64B | 10.33 | 8.33% | 5.31% | 6.81% | 1.69% | |
73 Outperform | ¥56.30B | 13.59 | ― | 2.54% | 3.47% | -12.26% | |
65 Neutral | ¥154.32B | 15.51 | ― | 3.47% | 4.99% | 20.74% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
52 Neutral | ¥87.03B | 27.23 | 5.02% | 3.23% | -21.03% | -91.77% |